Heart Failure and Advanced Therapies

Co-chairs:  Dr. Mahwash Kassi and Dr. Yevgeniy Khariton

Letter from Chair

Greetings!

 

We are pleased to bring this section website to the Texas ACC, targeting providers and multidisciplinary trainees that take care of patients with de novo or chronic heart failure as well as cardiac transplantation and durable mechanical support.  The proportion of patients with heart failure in the country is growing at an exponential pace.  Importantly, we now stand at a unique intersection bearing witness to significant breakthroughs in guideline medical therapies as well as imaging modalities to phenotype and treat ischemic and non-ischemic cardiomyopathies.  We have drug options for once-fatal disorders such as cardiac amyloidosis.  We have updated algorithms on how best to recognize and manage cardiogenic shock. We have multiple, robust mechanical platforms to treat univentricular and biventricular failure.  As a community, we pride ourselves in taking care of this vulnerable population and cherish each individual’s commitment to their care.

 

As the Texas ACC chairs for 2023-2024, we want to be this community’s best advocates and foster an environment of diversity and inclusion. Texas ACC chapter is your home to share, to innovate and to learn.  Let us leverage our combined knowledge and ingenuity to bring effective heart failure care across the state of Texas.  Included on our section site is a compartmentalized list of electronic learning and support resources that we will continue to update over time.   Our aim is to publish quarterly blogs targeting challenging and relevant issues in the heart failure specialty as well as highlight a publication of the month that best represents upcoming and innovative practice. We are here for you, and we look forward to any feedback from the community.

Richard A. Lange, MD

Letter from Chair

Greetings!

We are pleased to bring this section website to the Texas ACC, targeting providers and multidisciplinary trainees that take care of patients with de novo or chronic heart failure as well as cardiac transplantation and durable mechanical support.  The proportion of patients with heart failure in the country is growing at an exponential pace.  Importantly, we now stand at a unique intersection bearing witness to significant breakthroughs in guideline medical therapies as well as imaging modalities to phenotype and treat ischemic and non-ischemic cardiomyopathies.  We have drug options for once-fatal disorders such as cardiac amyloidosis.  We have updated algorithms on how best to recognize and manage cardiogenic shock. We have multiple, robust mechanical platforms to treat univentricular and biventricular failure.  As a community, we pride ourselves in taking care of this vulnerable population and cherish each individual’s commitment to their care.

Mahwash Kassi, MD

Yevgeniy Khariton, MD, MEd, MSc

As the Texas ACC chairs for 2023-2024, we want to be this community’s best advocates and foster an environment of diversity and inclusion. Texas ACC chapter is your home to share, to innovate and to learn.  Let us leverage our combined knowledge and ingenuity to bring effective heart failure care across the state of Texas.  Included on our section site is a compartmentalized list of electronic learning and support resources that we will continue to update over time.   Our aim is to publish quarterly blogs targeting challenging and relevant issues in the heart failure specialty as well as highlight a publication of the month that best represents upcoming and innovative practice. We are here for you, and we look forward to any feedback from the community.

Resources

Upcoming Events

No event found!

Join this TCACC Section